NCT06331130 Mesenteric Infiltration in Ovarian Cancer
| NCT ID | NCT06331130 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Ovary Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 510 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 510 participants in total. It began in 2024-03-01 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate if CT features at diagnosis in patients with HGSOC can be used to build an Artificial Intelligence model capable of discerning the pathological involvement of the mesentery, assessing the potential impediments for an optimal debulking surgery and predicting the development of resistance to platinum based chemotherapeutic agents.
Eligibility Criteria
Inclusion Criteria: 1. Women with confirmed HGSOC wiht mesenteric involvment 2. Age \> 18 years 3. FIGO STAGE IIIB-IV 4. Primary diagnosis 5. Signed informed consent Exclusion Criteria: 1. Non-serous high grade epithelial ovarian cancer (serous low grade, mucinous, clear cell carcinoma, endometrioid or non-epithelial ovarian cancer) 2. Early stage disease (I and II stage) 3. CT scan not available 4. Non-primary diagnosis or patient subjected to neoadjuvant chemotherapy
Contact & Investigator
Camilla Panico, Dr
PRINCIPAL INVESTIGATOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Frequently Asked Questions
Who can join the NCT06331130 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Ovary Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06331130 currently recruiting?
Yes, NCT06331130 is actively recruiting participants. Contact the research team at camilla.panico@policlinicogemelli.it for enrollment information.
Where is the NCT06331130 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT06331130 clinical trial?
NCT06331130 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The principal investigator is Camilla Panico, Dr at Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 510 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.